| | | | | | Product | Package Size | EFP | CP | SB | DC | Composition | Registr. Holder | Category | | |
|---|
| What is an ATC-Code? | ATC-Overview |
|
| | | IP | CI | | CoAprovel 150/12.5 - T | 28 Tablet(s) | 9.18 | 19.10 | 10 % | | Coated tablets: 2 Active Agents | Sanofi-Aventis
(Suisse) SA | B / SL / SO | FB | G |
| | | IP | CI | | CoAprovel 150/12.5 - T | 98 Tablet(s) | 29.64 | 48.20 | 10 % | | Coated tablets: 2 Active Agents | Sanofi-Aventis
(Suisse) SA | B / SL / SO | FB | G |
| | | IP | CI | | CoAprovel 300/12.5 - T | 28 Tablet(s) | 12.40 | 29.70 | 10 % | | Coated tablets: 2 Active Agents | Sanofi-Aventis
(Suisse) SA | B / SL / SO | FB | G |
| | | IP | CI | | CoAprovel 300/12.5 - T | 98 Tablet(s) | 42.83 | 62.35 | 10 % | | Coated tablets: 2 Active Agents | Sanofi-Aventis
(Suisse) SA | B / SL / SO | FB | G |
| | | IP | CI | | CoAprovel 300/25 - T | 28 Tablet(s) | 12.55 | 29.85 | 10 % | | Coated tablets: 2 Active Agents | Sanofi-Aventis
(Suisse) SA | B / SL / SO | FB | G |
| | | IP | CI | | CoAprovel 300/25 - T | 98 Tablet(s) | 43.34 | 62.90 | 10 % | | Coated tablets: 2 Active Agents | Sanofi-Aventis
(Suisse) SA | B / SL / SO | FB | G |
| | | IP | CI | | Co-Irbesartan Sandoz
150/12,5 mg | 28 Tablet(s) | 6.89 | 16.75 | 10 % | | Coated tablets: 2 Active Agents | Sandoz
Pharmaceuticals AG | B / SL / SG | FB | G |
| | | IP | CI | | Co-Irbesartan Sandoz
150/12,5 mg | 98 Tablet(s) | 22.22 | 40.60 | 10 % | | Coated tablets: 2 Active Agents | Sandoz
Pharmaceuticals AG | B / SL / SG | FB | G |
| | | IP | CI | | Co-Irbesartan Sandoz
300/12,5 mg | 28 Tablet(s) | 9.30 | 26.55 | 10 % | | Coated tablets: 2 Active Agents | Sandoz
Pharmaceuticals AG | B / SL / SG | FB | G |
| | | IP | CI | | Co-Irbesartan Sandoz
300/12,5 mg | 98 Tablet(s) | 32.12 | 51.35 | 10 % | | Coated tablets: 2 Active Agents | Sandoz
Pharmaceuticals AG | B / SL / SG | FB | G |
| | | IP | CI | | Co-Irbesartan Sandoz
300/25 mg | 28 Tablet(s) | 9.41 | 26.65 | 10 % | | Coated tablets: 2 Active Agents | Sandoz
Pharmaceuticals AG | B / SL / SG | FB | G |
| | | IP | CI | | Co-Irbesartan Sandoz
300/25 mg | 98 Tablet(s) | 32.50 | 51.75 | 10 % | | Coated tablets: 2 Active Agents | Sandoz
Pharmaceuticals AG | B / SL / SG | FB | G |
| | | IP | CI | | Co-Irbesartan Spirig HC
150/12.5 mg | 28 Tablet(s) | 6.89 | 16.75 | 10 % | | Coated tablets: 2 Active Agents | Spirig HealthCare AG | B / SL / SG | FB | G |
| | | IP | CI | | Co-Irbesartan Spirig HC
150/12.5 mg | 98 Tablet(s) | 22.22 | 40.60 | 10 % | | Coated tablets: 2 Active Agents | Spirig HealthCare AG | B / SL / SG | FB | G |
| | | IP | CI | | Co-Irbesartan Spirig HC
300/12.5 mg | 28 Tablet(s) | 9.30 | 26.55 | 10 % | | Coated tablets: 2 Active Agents | Spirig HealthCare AG | B / SL / SG | FB | G |
| | | IP | CI | | Co-Irbesartan Spirig HC
300/12.5 mg | 98 Tablet(s) | 32.12 | 51.35 | 10 % | | Coated tablets: 2 Active Agents | Spirig HealthCare AG | B / SL / SG | FB | G |
| | | IP | CI | | Irbesartan HCT Zentiva
150/12.5 mg | 28 Tablet(s) | 6.89 | 16.75 | 10 % | | Coated tablets: 2 Active Agents | Helvepharm AG | B / SL / SG | FB | G |
| | | IP | CI | | Irbesartan HCT Zentiva
150/12.5 mg | 98 Tablet(s) | 22.23 | 40.60 | 10 % | | Coated tablets: 2 Active Agents | Helvepharm AG | B / SL / SG | FB | G |
| | | IP | CI | | Irbesartan HCT Zentiva
300/12.5 mg | 28 Tablet(s) | 9.30 | 26.55 | 10 % | | Coated tablets: 2 Active Agents | Helvepharm AG | B / SL / SG | FB | G |
| | | IP | CI | | Irbesartan HCT Zentiva
300/12.5 mg | 98 Tablet(s) | 32.12 | 51.35 | 10 % | | Coated tablets: 2 Active Agents | Helvepharm AG | B / SL / SG | FB | G |
| | | IP | CI | | Irbesartan HCT Zentiva
300/25 mg | 28 Tablet(s) | 9.41 | 26.65 | 10 % | | Coated tablets: 2 Active Agents | Helvepharm AG | ● B / SL / SG | FB | G |
| | | IP | CI | | Irbesartan HCT Zentiva
300/25 mg | 98 Tablet(s) | 32.51 | 51.75 | 10 % | | Coated tablets: 2 Active Agents | Helvepharm AG | ● B / SL / SG | FB | G |
| | | IP | CI | | Irbesartan-HCT-Mepha
150mg/12.5mg | 28 Tablet(s) | 6.89 | 16.75 | 10 % | | Coated tablets: 2 Active Agents | Mepha Pharma AG | B / SL / SG | FB | G |
| | | IP | CI | | Irbesartan-HCT-Mepha
150mg/12.5mg | 98 Tablet(s) | 22.23 | 40.60 | 10 % | | Coated tablets: 2 Active Agents | Mepha Pharma AG | B / SL / SG | FB | G |
| | | IP | CI | | Irbesartan-HCT-Mepha
300mg/12.5mg | 28 Tablet(s) | 9.31 | 26.55 | 10 % | | Coated tablets: 2 Active Agents | Mepha Pharma AG | B / SL / SG | FB | G |
| | | IP | CI | | Irbesartan-HCT-Mepha
300mg/12.5mg | 98 Tablet(s) | 32.12 | 51.35 | 10 % | | Coated tablets: 2 Active Agents | Mepha Pharma AG | B / SL / SG | FB | G |
| | | IP | CI | | Irbesartan-HCT-Mepha
300mg/25mg | 28 Tablet(s) | 9.42 | 26.65 | 10 % | | Coated tablets: 2 Active Agents | Mepha Pharma AG | B / SL / SG | FB | G |
| | | IP | CI | | Irbesartan-HCT-Mepha
300mg/25mg | 98 Tablet(s) | 32.51 | 51.75 | 10 % | | Coated tablets: 2 Active Agents | Mepha Pharma AG | B / SL / SG | FB | G |
| | | IP | CI | | Co-Irbesartan Spirig HC
300/25 mg | 28 Tablet(s) | 9.41 | 26.65 | 10 % | | Filmtablette: 2 Active Agents | Spirig HealthCare AG | B / SL / SG | FB | G |
| | | IP | CI | | Co-Irbesartan Spirig HC
300/25 mg | 98 Tablet(s) | 32.50 | 51.75 | 10 % | | Filmtablette: 2 Active Agents | Spirig HealthCare AG | B / SL / SG | FB | G |
|
| | | IP | CI | | Atacand plus 8/12.5 mg | 28 Tablet(s) | 8.29 | 18.15 | 10 % | | Tablets: 2 Active Agents | Cheplapharm Schweiz
GmbH | B / SL / SO | FB | G |
| | | IP | CI | | Atacand plus 8/12.5 mg | 98 Tablet(s) | 27.09 | 45.50 | 10 % | | Tablets: 2 Active Agents | Cheplapharm Schweiz
GmbH | B / SL / SO | FB | G |
| | | IP | CI | | Atacand plus 16/12.5 mg ‐ I | 28 Tablet(s) | 10.27 | 27.45 | 10 % | | Tablets: 2 Active Agents | Cheplapharm Schweiz
GmbH | ● B / SL / SO | FB | G |
| | | IP | CI | | Atacand plus 16/12.5 mg ‐ I | 98 Tablet(s) | 35.85 | 54.90 | 10 % | | Tablets: 2 Active Agents | Cheplapharm Schweiz
GmbH | B / SL / SO | FB | G |
| | | IP | CI | | Atacand plus 32/12.5 mg | 28 Tablet(s) | 11.35 | 28.60 | 10 % | | Tablets: 2 Active Agents | Cheplapharm Schweiz
GmbH | B / SL / SO | FB | G |
| | | IP | CI | | Atacand plus 32/12.5 mg | 98 Tablet(s) | 37.38 | 56.60 | 10 % | | Tablets: 2 Active Agents | Cheplapharm Schweiz
GmbH | B / SL / SO | FB | G |
| | | IP | CI | | Atacand plus 32/25 mg | 28 Tablet(s) | 11.35 | 28.60 | 10 % | | Tablets: 2 Active Agents | Cheplapharm Schweiz
GmbH | B / SL / SO | FB | G |
| | | IP | CI | | Atacand plus 32/25 mg | 98 Tablet(s) | 37.38 | 56.60 | 10 % | | Tablets: 2 Active Agents | Cheplapharm Schweiz
GmbH | B / SL / SO | FB | G |
| | | IP | CI | | Blopress Plus 8/12.5 mg | 28 Tablet(s) | 8.29 | 18.15 | 10 % | | Tablets: 2 Active Agents | Cheplapharm Schweiz
GmbH | ● B / SL / SO | FB | G |
| | | IP | CI | | Blopress Plus 8/12.5 mg | 98 Tablet(s) | 27.09 | 45.50 | 10 % | | Tablets: 2 Active Agents | Cheplapharm Schweiz
GmbH | B / SL / SO | FB | G |
| | | IP | CI | | Blopress Plus 16/12.5 mg | 28 Tablet(s) | 10.27 | 27.45 | 10 % | | Tablets: 2 Active Agents | Cheplapharm Schweiz
GmbH | ● B / SL / SO | FB | G |
| | | IP | CI | | Blopress Plus 16/12.5 mg | 98 Tablet(s) | 35.85 | 54.90 | 10 % | | Tablets: 2 Active Agents | Cheplapharm Schweiz
GmbH | B / SL / SO | FB | G |
| | | IP | CI | | Blopress Plus 32/12.5 mg | 28 Tablet(s) | 11.14 | 28.40 | 10 % | | Tablets: 2 Active Agents | Cheplapharm Schweiz
GmbH | ● B / SL / SO | FB | G |
| | | IP | CI | | Blopress Plus 32/12.5 mg | 98 Tablet(s) | 37.38 | 56.60 | 10 % | | Tablets: 2 Active Agents | Cheplapharm Schweiz
GmbH | B / SL / SO | FB | G |
| | | IP | CI | | Blopress Plus 32/25 mg | 28 Tablet(s) | 11.75 | 29.00 | 10 % | | Tablets: 2 Active Agents | Cheplapharm Schweiz
GmbH | B / SL / SO | FB | G |
| | | IP | CI | | Blopress Plus 32/25 mg | 98 Tablet(s) | 37.38 | 56.60 | 10 % | | Tablets: 2 Active Agents | Cheplapharm Schweiz
GmbH | B / SL / SO | FB | G |
| | | IP | CI | CM | CANDESARTAN PLUS
CHEPLAPHARM 8/12.5 mg | 98 | 27.09 | 45.50 | 10 % | | Tablets: 2 Active Agents | Cheplapharm Schweiz
GmbH | B / SL / SO | FB | G |
| | | IP | CI | CM | CANDESARTAN PLUS
CHEPLAPHARM 16/12.5 mg | 98 | 35.85 | 54.90 | 10 % | | Tablets: 2 Active Agents | Cheplapharm Schweiz
GmbH | B / SL / SO | FB | G |
| | | IP | CI | CM | CANDESARTAN PLUS
CHEPLAPHARM 32/12.5 mg | 98 | 37.38 | 56.60 | 10 % | | Tablets: 2 Active Agents | Cheplapharm Schweiz
GmbH | B / SL / SO | FB | G |
| | | IP | CI | CM | CANDESARTAN PLUS
CHEPLAPHARM 32/25 mg | 98 | 37.38 | 56.60 | 10 % | | Tablets: 2 Active Agents | Cheplapharm Schweiz
GmbH | B / SL / SO | FB | G |
| | | IP | CI | | Pemzek PLUS 8/12.5 mg | 28 Tablet(s) | 8.29 | 18.15 | 10 % | | Tablets: 2 Active Agents | AstraZeneca AG | B / SL / SO | FB | G |
| | | IP | CI | | Pemzek PLUS 8/12.5 mg | 98 Tablet(s) | 27.09 | 45.50 | 10 % | | Tablets: 2 Active Agents | AstraZeneca AG | B / SL / SO | FB | G |
| | | IP | CI | | Pemzek PLUS 16/12.5 mg | 28 Tablet(s) | 10.26 | 27.45 | 10 % | | Tablets: 2 Active Agents | AstraZeneca AG | B / SL / SO | FB | G |
| | | IP | CI | | Pemzek PLUS 16/12.5 mg | 98 Tablet(s) | 35.85 | 54.90 | 10 % | | Tablets: 2 Active Agents | AstraZeneca AG | B / SL / SO | FB | G |
| | | IP | CI | | Pemzek PLUS 32/12.5 mg | 28 Tablet(s) | 14.94 | 32.30 | 10 % | | Tablets: 2 Active Agents | AstraZeneca AG | B / SL / SO | FB | G |
| | | IP | CI | | Pemzek PLUS 32/12.5 mg | 98 Tablet(s) | 37.38 | 56.60 | 10 % | | Tablets: 2 Active Agents | AstraZeneca AG | B / SL / SO | FB | G |
| | | IP | CI | | Pemzek PLUS 32/25 mg | 28 Tablet(s) | 14.94 | 32.30 | 10 % | | Tablets: 2 Active Agents | AstraZeneca AG | B / SL / SO | FB | G |
| | | IP | CI | | Pemzek PLUS 32/25 mg | 98 Tablet(s) | 37.38 | 56.60 | 10 % | | Tablets: 2 Active Agents | AstraZeneca AG | B / SL / SO | FB | G |
| | | IP | CI | | Candesartan HCT Zentiva
8/12.5mg | 30 | 6.67 | 16.50 | 10 % | | Tablets: 2 Active Agents | Helvepharm AG | B / SL / SG | FB | G |
| | | IP | CI | | Candesartan HCT Zentiva
8/12.5mg | 100 | 20.73 | 39.00 | 10 % | | Tablets: 2 Active Agents | Helvepharm AG | B / SL / SG | FB | G |
| | | IP | CI | | Candesartan HCT Zentiva
16/12.5mg | 30 | 8.26 | 25.40 | 10 % | | Tablets: 2 Active Agents | Helvepharm AG | B / SL / SG | FB | G |
| | | IP | CI | | Candesartan HCT Zentiva
16/12.5mg | 100 | 27.44 | 46.30 | 10 % | | Tablets: 2 Active Agents | Helvepharm AG | B / SL / SG | FB | G |
| | | IP | CI | | Candesartan HCT Zentiva
32/12.5mg | 28 | 8.92 | 26.10 | 10 % | | Tablets: 2 Active Agents | Helvepharm AG | B / SL / SG | FB | G |
| | | IP | CI | | Candesartan HCT Zentiva
32/12.5mg | 98 | 30.28 | 49.30 | 10 % | | Tablets: 2 Active Agents | Helvepharm AG | B / SL / SG | FB | G |
| | | IP | CI | | Candesartan HCT Zentiva
32/25 mg | 28 | 8.92 | 26.10 | 10 % | | Tablets: 2 Active Agents | Helvepharm AG | B / SL / SG | FB | G |
| | | IP | CI | | Candesartan HCT Zentiva
32/25 mg | 98 | 30.28 | 49.30 | 10 % | | Tablets: 2 Active Agents | Helvepharm AG | B / SL / SG | FB | G |
| | | IP | CI | | Cansartan-Mepha plus
8/12.5 | 28 Tablet(s) | 7.04 | 16.85 | 10 % | | Tablets: 2 Active Agents | Mepha Pharma AG | B / SL / SG | FB | G |
| | | IP | CI | | Cansartan-Mepha plus
8/12.5 | 98 Tablet(s) | 23.03 | 41.35 | 10 % | | Tablets: 2 Active Agents | Mepha Pharma AG | B / SL / SG | FB | G |
| | | IP | CI | | Cansartan-Mepha plus
16/12.5 | 28 Tablet(s) | 8.73 | 25.85 | 10 % | | Tablets: 2 Active Agents | Mepha Pharma AG | B / SL / SG | FB | G |
| | | IP | CI | | Cansartan-Mepha plus
16/12.5 | 98 Tablet(s) | 30.47 | 49.40 | 10 % | | Tablets: 2 Active Agents | Mepha Pharma AG | B / SL / SG | FB | G |
| | | IP | CI | | Cansartan-Mepha plus
32/12.5 | 28 Tablet(s) | 9.53 | 26.75 | 10 % | | Tablets: 2 Active Agents | Mepha Pharma AG | B / SL / SG | FB | G |
| | | IP | CI | | Cansartan-Mepha plus
32/12.5 | 98 Tablet(s) | 31.36 | 50.40 | 10 % | | Tablets: 2 Active Agents | Mepha Pharma AG | B / SL / SG | FB | G |
| | | IP | CI | | Cansartan-Mepha plus
32/25 | 28 Tablet(s) | 9.53 | 26.75 | 10 % | | Tablets: 2 Active Agents | Mepha Pharma AG | B / SL / SG | FB | G |
| | | IP | CI | | Cansartan-Mepha plus
32/25 | 98 Tablet(s) | 31.36 | 50.40 | 10 % | | Tablets: 2 Active Agents | Mepha Pharma AG | B / SL / SG | FB | G |
| | | IP | CI | | Co-Candesartan Sandoz
8/12.5 mg | 28 Tablet(s) | 6.22 | 16.00 | 10 % | | Tablets: 2 Active Agents | Sandoz
Pharmaceuticals AG | B / SL / SG | FB | G |
| | | IP | CI | | Co-Candesartan Sandoz
8/12.5 mg | 98 Tablet(s) | 20.32 | 38.55 | 10 % | | Tablets: 2 Active Agents | Sandoz
Pharmaceuticals AG | B / SL / SG | FB | G |
| | | IP | CI | | Co-Candesartan Sandoz
16/12.5 mg | 28 Tablet(s) | 7.70 | 24.80 | 10 % | | Tablets: 2 Active Agents | Sandoz
Pharmaceuticals AG | B / SL / SG | FB | G |
| | | IP | CI | | Co-Candesartan Sandoz
16/12.5 mg | 98 Tablet(s) | 26.89 | 45.70 | 10 % | | Tablets: 2 Active Agents | Sandoz
Pharmaceuticals AG | B / SL / SG | FB | G |
| | | IP | CI | | Co-Candesartan Sandoz
32/12.5 mg | 28 Tablet(s) | 8.56 | 25.75 | 10 % | | Tablets: 2 Active Agents | Sandoz
Pharmaceuticals AG | B / SL / SG | FB | G |
| | | IP | CI | | Co-Candesartan Sandoz
32/12.5 mg | 98 Tablet(s) | 28.19 | 47.15 | 10 % | | Tablets: 2 Active Agents | Sandoz
Pharmaceuticals AG | B / SL / SG | FB | G |
| | | IP | CI | | Co-Candesartan Sandoz
32/25 mg | 28 Tablet(s) | 8.56 | 25.75 | 10 % | | Tablets: 2 Active Agents | Sandoz
Pharmaceuticals AG | B / SL / SG | FB | G |
| | | IP | CI | | Co-Candesartan Sandoz
32/25 mg | 98 Tablet(s) | 28.19 | 47.15 | 10 % | | Tablets: 2 Active Agents | Sandoz
Pharmaceuticals AG | B / SL / SG | FB | G |
| | | IP | CI | | Co-Candesartan Spirig HC
8/12,5mg | 28 | 6.21 | 16.00 | 10 % | | Tablets: 2 Active Agents | Spirig HealthCare AG | B / SL / SG | FB | G |
| | | IP | CI | | Co-Candesartan Spirig HC
8/12,5mg | 98 | 20.32 | 38.55 | 10 % | | Tablets: 2 Active Agents | Spirig HealthCare AG | B / SL / SG | FB | G |
| | | IP | CI | | Co-Candesartan Spirig HC
16/12,5mg | 28 | 7.67 | 24.80 | 10 % | | Tablets: 2 Active Agents | Spirig HealthCare AG | B / SL / SG | FB | G |
| | | IP | CI | | Co-Candesartan Spirig HC
16/12,5mg | 98 | 26.89 | 45.70 | 10 % | | Tablets: 2 Active Agents | Spirig HealthCare AG | B / SL / SG | FB | G |
| | | IP | CI | | Co-Candesartan Spirig HC
32/12,5mg | 28 | 8.57 | 25.75 | 10 % | | Tablets: 2 Active Agents | Spirig HealthCare AG | B / SL / SG | FB | G |
| | | IP | CI | | Co-Candesartan Spirig HC
32/12,5mg | 98 | 28.22 | 47.20 | 10 % | | Tablets: 2 Active Agents | Spirig HealthCare AG | B / SL / SG | FB | G |
| | | IP | CI | | Co-Candesartan Spirig HC
32/25mg | 28 | 8.57 | 25.75 | 10 % | | Tablets: 2 Active Agents | Spirig HealthCare AG | B / SL / SG | FB | G |
| | | IP | CI | | Co-Candesartan Spirig HC
32/25mg | 98 | 28.22 | 47.20 | 10 % | | Tablets: 2 Active Agents | Spirig HealthCare AG | B / SL / SG | FB | G |
| | | IP | CI | | Atacand plus 8/12.5 mg | 30 | | | k.A. | | Tablets: 2 Active Agents | Cheplapharm Schweiz
GmbH | B | FB | G |
| | | IP | CI | | Atacand plus 16/12.5 mg | 30 | | | k.A. | | Tablets: 2 Active Agents | Cheplapharm Schweiz
GmbH | B | FB | G |
| | | IP | CI | CM | CANDESARTAN PLUS
CHEPLAPHARM 8/12.5 mg | 28 | | | k.A. | | Tablets: 2 Active Agents | Cheplapharm Schweiz
GmbH | B | FB | G |
| | | IP | CI | CM | CANDESARTAN PLUS
CHEPLAPHARM 16/12.5 mg | 28 | | | k.A. | | Tablets: 2 Active Agents | Cheplapharm Schweiz
GmbH | B | FB | G |
| | | IP | CI | CM | CANDESARTAN PLUS
CHEPLAPHARM 32/12.5 mg | 28 | | | k.A. | | Tablets: 2 Active Agents | Cheplapharm Schweiz
GmbH | B | FB | G |
| | | IP | CI | CM | CANDESARTAN PLUS
CHEPLAPHARM 32/25 mg | 28 | | | k.A. | | Tablets: 2 Active Agents | Cheplapharm Schweiz
GmbH | B | FB | G |
| | | IP | CI | | Pemzek PLUS 8/12.5 mg | 30 | | | k.A. | | Tablets: 2 Active Agents | AstraZeneca AG | B | FB | G |
| | | IP | CI | | Pemzek PLUS 16/12.5 mg | 30 | | | k.A. | | Tablets: 2 Active Agents | AstraZeneca AG | B | FB | G |
|
| | | IP | CI | PP | Edarbyclor 40 mg/12.5 mg | 28 Tablet(s) | 23.28 | 41.75 | 10 % | | Coated tablets: 2 Active Agents | Takeda Pharma AG | B / SL | FB | G |
| | | IP | CI | PP | Edarbyclor 40 mg/12.5 mg | 98 Tablet(s) | 76.36 | 99.45 | 10 % | | Coated tablets: 2 Active Agents | Takeda Pharma AG | B / SL | FB | G |
| | | IP | CI | PP | Edarbyclor 40 mg/25 mg | 28 Tablet(s) | 24.41 | 42.95 | 10 % | | Coated tablets: 2 Active Agents | Takeda Pharma AG | B / SL | FB | G |
| | | IP | CI | PP | Edarbyclor 40 mg/25 mg | 98 Tablet(s) | 80.06 | 103.50 | 10 % | | Coated tablets: 2 Active Agents | Takeda Pharma AG | B / SL | FB | G |
| | | IP | CI | PP | Edarbyclor 40 mg/12.5 mg | 56 Tablet(s) | | | k.A. | | Coated tablets: 2 Active Agents | Takeda Pharma AG | B | FB | G |
| | | IP | CI | PP | Edarbyclor 40 mg/25 mg | 56 Tablet(s) | | | k.A. | | Coated tablets: 2 Active Agents | Takeda Pharma AG | B | FB | G |
|
| L | | IP | CI | | Candesartan Amlodipin
Sandoz 8 mg/5 mg | 28 | 14.54 | 32.25 | 10 % | | Capsules: 2 Active Agents | Sandoz
Pharmaceuticals AG | B / SL | FB | G |
| L | | IP | CI | | Candesartan Amlodipin
Sandoz 8 mg/5 mg | 98 | 43.16 | 63.35 | 10 % | | Capsules: 2 Active Agents | Sandoz
Pharmaceuticals AG | ● B / SL | FB | G |
| L | | IP | CI | | Candesartan Amlodipin
Sandoz 8 mg/10 mg | 28 | 17.98 | 35.95 | 10 % | | Capsules: 2 Active Agents | Sandoz
Pharmaceuticals AG | B / SL | FB | G |
| L | | IP | CI | | Candesartan Amlodipin
Sandoz 8 mg/10 mg | 98 | 62.93 | 84.85 | 10 % | | Capsules: 2 Active Agents | Sandoz
Pharmaceuticals AG | B / SL | FB | G |
| L | | IP | CI | | Candesartan Amlodipin
Sandoz 16 mg/5 mg | 28 | 15.91 | 33.70 | 10 % | | Capsules: 2 Active Agents | Sandoz
Pharmaceuticals AG | B / SL | FB | G |
| L | | IP | CI | | Candesartan Amlodipin
Sandoz 16 mg/5 mg | 98 | 49.82 | 70.60 | 10 % | | Capsules: 2 Active Agents | Sandoz
Pharmaceuticals AG | B / SL | FB | G |
| L | | IP | CI | | Candesartan Amlodipin
Sandoz 16 mg/10 mg | 28 | 19.35 | 37.45 | 10 % | | Capsules: 2 Active Agents | Sandoz
Pharmaceuticals AG | B / SL | FB | G |
| L | | IP | CI | | Candesartan Amlodipin
Sandoz 16 mg/10 mg | 98 | 67.73 | 90.10 | 10 % | | Capsules: 2 Active Agents | Sandoz
Pharmaceuticals AG | B / SL | FB | G |
| L | | IP | CI | | Candesartan-Amlodipin-
Mepha 8 mg/5 mg | 28 | 14.54 | 32.25 | 10 % | | Capsules: 2 Active Agents | Mepha Pharma AG | B / SL | FB | G |
| L | | IP | CI | | Candesartan-Amlodipin-
Mepha 8 mg/5 mg | 98 | 43.16 | 63.35 | 10 % | | Capsules: 2 Active Agents | Mepha Pharma AG | B / SL | FB | G |
| L | | IP | CI | | Candesartan-Amlodipin-
Mepha 8 mg/10 mg | 28 | 17.98 | 35.95 | 10 % | | Capsules: 2 Active Agents | Mepha Pharma AG | B / SL | FB | G |
| L | | IP | CI | | Candesartan-Amlodipin-
Mepha 8 mg/10 mg | 98 | 62.93 | 84.85 | 10 % | | Capsules: 2 Active Agents | Mepha Pharma AG | B / SL | FB | G |
| L | | IP | CI | | Candesartan-Amlodipin-
Mepha 16 mg/5 mg | 28 | 15.91 | 33.70 | 10 % | | Capsules: 2 Active Agents | Mepha Pharma AG | B / SL | FB | G |
| L | | IP | CI | | Candesartan-Amlodipin-
Mepha 16 mg/5 mg | 98 | 49.82 | 70.60 | 10 % | | Capsules: 2 Active Agents | Mepha Pharma AG | B / SL | FB | G |
| L | | IP | CI | | Candesartan-Amlodipin-
Mepha 16 mg/10 mg | 28 | 19.35 | 37.45 | 10 % | | Capsules: 2 Active Agents | Mepha Pharma AG | B / SL | FB | G |
| L | | IP | CI | | Candesartan-Amlodipin-
Mepha 16 mg/10 mg | 98 | 67.73 | 90.10 | 10 % | | Capsules: 2 Active Agents | Mepha Pharma AG | B / SL | FB | G |
